Abstract

Summary

The paper discusses the potential of retinal ganglion cell (RGC) repopulation as a therapeutic approach to reverse vision loss from optic neuropathies, and the challenges and questions that need to be addressed to bring this approach towards clinical translation.
Categories

Categories

Eye health: The paper focuses on the potential of retinal ganglion cell (RGC) repopulation to restore vision loss from optic neuropathies, discussing the challenges and questions that need to be addressed to bring this approach towards clinical translation.
Aging: The paper discusses optic neuropathies, which are often age-related, and the potential of RGC repopulation as a therapeutic approach to reverse vision loss from these conditions.
Authors

Author(s)

JR Soucy, EA Aguzzi, J Cho, MJ Gilhooley
Publication Date

Publication Year

2023
Citations

Number of Citations

4
View more publications